Genetic Modifications to Alter Blood Pressure Level

Genetic manipulation is one of the indispensable techniques to examine gene functions both in vitro and in vivo. In particular, cardiovascular phenotypes such as blood pressure cannot be evaluated in vitro system, necessitating the creation of transgenic or gene-targeted knock-out and knock-in exper...

Full description

Bibliographic Details
Main Authors: Hiroki Ohara, Toru Nabika
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/8/1855
_version_ 1797432448997392384
author Hiroki Ohara
Toru Nabika
author_facet Hiroki Ohara
Toru Nabika
author_sort Hiroki Ohara
collection DOAJ
description Genetic manipulation is one of the indispensable techniques to examine gene functions both in vitro and in vivo. In particular, cardiovascular phenotypes such as blood pressure cannot be evaluated in vitro system, necessitating the creation of transgenic or gene-targeted knock-out and knock-in experimental animals to understand the pathophysiological roles of specific genes on the disease conditions. Although genome-wide association studies (GWAS) in various human populations have identified multiple genetic variations associated with increased risk for hypertension and/or its complications, the causal links remain unresolved. Genome-editing technologies can be applied to many different types of cells and organisms for creation of knock-out/knock-in models. In the post-GWAS era, it may be more worthwhile to validate pathophysiological implications of the risk variants and/or candidate genes by creating genome-edited organisms.
first_indexed 2024-03-09T10:00:40Z
format Article
id doaj.art-af6cfbe491d04e3180f94f7201f06896
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T10:00:40Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-af6cfbe491d04e3180f94f7201f068962023-12-01T23:27:26ZengMDPI AGBiomedicines2227-90592022-08-01108185510.3390/biomedicines10081855Genetic Modifications to Alter Blood Pressure LevelHiroki Ohara0Toru Nabika1Department of Functional Pathology, Faculty of Medicine, Shimane University, Izumo 693-8501, JapanDepartment of Functional Pathology, Faculty of Medicine, Shimane University, Izumo 693-8501, JapanGenetic manipulation is one of the indispensable techniques to examine gene functions both in vitro and in vivo. In particular, cardiovascular phenotypes such as blood pressure cannot be evaluated in vitro system, necessitating the creation of transgenic or gene-targeted knock-out and knock-in experimental animals to understand the pathophysiological roles of specific genes on the disease conditions. Although genome-wide association studies (GWAS) in various human populations have identified multiple genetic variations associated with increased risk for hypertension and/or its complications, the causal links remain unresolved. Genome-editing technologies can be applied to many different types of cells and organisms for creation of knock-out/knock-in models. In the post-GWAS era, it may be more worthwhile to validate pathophysiological implications of the risk variants and/or candidate genes by creating genome-edited organisms.https://www.mdpi.com/2227-9059/10/8/1855knock-outgenome-editingSHRSHRSPDahl SS
spellingShingle Hiroki Ohara
Toru Nabika
Genetic Modifications to Alter Blood Pressure Level
Biomedicines
knock-out
genome-editing
SHR
SHRSP
Dahl SS
title Genetic Modifications to Alter Blood Pressure Level
title_full Genetic Modifications to Alter Blood Pressure Level
title_fullStr Genetic Modifications to Alter Blood Pressure Level
title_full_unstemmed Genetic Modifications to Alter Blood Pressure Level
title_short Genetic Modifications to Alter Blood Pressure Level
title_sort genetic modifications to alter blood pressure level
topic knock-out
genome-editing
SHR
SHRSP
Dahl SS
url https://www.mdpi.com/2227-9059/10/8/1855
work_keys_str_mv AT hirokiohara geneticmodificationstoalterbloodpressurelevel
AT torunabika geneticmodificationstoalterbloodpressurelevel